Sains Malaysiana 48(3)(2019): 613–619
            
          
              http://dx.doi.org/10.17576/jsm-2019-4803-14 
                 
          
             
          
          Blood
            Inflammatory Markers, Anabolic Hormone, Vitamin D and L-Carnitine Status
            According to Frailty Status among Older Adults
            
          
          (Penanda
            Inflamasi Darah, Hormon Anabolik, Vitamin D dan Status L-Karnitin menurut
            Status Keuzuran dalam Kalangan Warga Emas)
            
          
          
             
          
          MANAL BADRASAWI1,2, SUZANA SHAHAR1*, NOR FADILAH RAJAB3 & DEVINDER KAUR AJIT SINGH4
            
          
          
             
          
          1Dietetic, Programme
            and Centre for Healthy Aging and Wellness, Faculty of Health Sciences, Universiti
            Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur, Federal
            Territory, Malaysia
            
          
          
             
          
          2Nutrition
            and Food Technology, Faculty of Agriculture, An-Najah National University, Palestine
            
          
          
             
          
          3Biomedical
            Programme and Centre of Healthy Aging and Wellness, Faculty of Health Science,
            School of Healthcare Sciences, Universiti Kebangsaan Malaysia, Jalan Raja Muda
            Abdul Aziz, 50300 Kuala Lumpur, Federal Territory, Malaysia
            
          
          
             
          
          4Physiotherapy
            Programme and Centre for Rehabilitation and Special Needs, Faculty of Health
            Sciences, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300
            Kuala Lumpur, Federal Territory, Malaysia
            
          
          
             
          
          Diserahkan: 24 April 2018/Diterima: 9 Januari 2019
            
          
          
             
          
          ABSTRACT
            
          
          Frailty is associated with functional decline and reduced ability
            to cope with physiological challenges. The pathophysiological changes in
            frailty include inflammation, endocrine disturbances, neuromuscular and immune
            dysfunction. However, comprehensive information on the relationship between
            biological markers and frailty is scarce. We aimed to determine the
            relationship between selected biomarkers and frailty among Malaysian older
            adults. In this cross sectional study, 600 community dwelling older adults were
            randomly selected from ten different areas in Klang Valley. A total of 382
            participants met the inclusion criteria and consented to the study. Out of
            these, a subsamples of 91 participants were selected for biomarkers analysis.
            Frailty was defined using Fried’s criteria. Fasting blood glucose, lipid
            profile, albumin, selected frailty biomarkers including IL-6, TNF-
            alpha and IGF-1 and vitamin D together with free L-carnitine and
            acetyl L-carnitine were analysed. The results showed a significantly higher
            level of serum IL-6 and TNF-α among participants
            classified as frail as compared to pre-frail and robust (p<0.05). With respect to nutritional
              biomarkers, binary logistic regression showed that vitamin D deficiency is
              associated with three times higher risk of frailty (p<0.05). There
                was no significant relationship between blood L-carnitines and frailty. Further
                research is required to explore the relationship between L-carnitine and
                frailty using different parameters involved in L-carnitine homeostasis such as CPTII enzyme and OCTN2 mutation. In conclusion, frailty
                was associated with increased level of inflammatory markers and vitamin D
                deficiency. It is empirical to promote healthy lifestyle or disease management
                to reduce inflammation and increase vitamin D status as one of the frailty
                prevention action plan among older adults.
  
           
            
          
          Keywords: Anabolic hormone; frailty biomarkers; inflammatory
            mediators; L-carnitine; vitamin D
            
          
          
             
          
          ABSTRAK
            
          
          Keuzuran adalah berkaitan dengan kemerosotan status kefungisan dan
            keupayaan dalam menangani cabaran fisiologi. Perubahan patofisiologi keuzuran
            termasuklah ketakfungsian ototneuro, ketakupayaan fungsi imun, inflamasi dan
            gangguan endokrin. Namun begitu, tidak banyak penyelidikan yang mengkaji
            hubungan antara petunjuk biologi dan keuzuran secara menyeluruh. Oleh itu,
            kajian ini menentukan hubungan antara petunjuk biologi tertentu dan status
            keuzuran dalam kalangan warga emas. Seramai 600 orang warga emas daripada
            komuniti dipilih secara rawak dari 10 buah kawasan di Lembah Klang. Seramai 382
            peserta memenuhi kriteria kajian dan bersetuju mengambil bahagian. Seramai 91
            subjek dipilih daripada sampel keseluruhan untuk analisis petunjuk biologi.
            Keuzuran didefinasikan daripada kriteria Fried. Petunjuk biokimia keuzuran yang
            dikaji termasuk IL-6, TNF-
            alfa dan IGF-1 serta vitamin D, bersama-sama dengan L-karnitin
            bebas dan asetil L-karnitin dianalisis. Keputusan menunjukkan aras plasma darah
            IL-6 dan TNF-α adalah lebih tinggi secara signifikan dalam
            kumpulan uzur berbanding, prauzur dan robus (p<0.05). Berhubung dengan petunjuk biologi pemakanan,
              analisis logistik binari menunjukkan kekurangan vitamin D berkaitan dengan
              risiko keuzuran sebanyak tiga kali ganda (p<0.05). Tiada hubungan
                signifikan antara L-karnitin dalam plasma darah dengan keuzuran, oleh itu,
                penyelidikan lanjut diperlukan untuk mengkaji hubungan antara homeostasis
                L-karnitin seperti enzim CPTII dengan mutasi OCTN2.
                Kesimpulannya, keuzuran dikaitkan dengan peningkatan tahap penanda inflamasi
                dan kekurangan vitamin D. Terdapat keperluan untuk meningkatkan strategi
                promosi gaya hidup sihat atau pengurusan penyakit untuk menurunkan tahap
                keradangan dan meningkatkan aras vitamin D bagi mencegah keuzuran dalam
                kalangan warga emas.
  
          
             
          
          Kata kunci: Keuzuran; L-karnitin; pengantara inflamasi; petunjuk
            biologi; vitamin D
            
          
          
             
          
          RUJUKAN
            
          
          
             
          
          Almeida, O.P., Norman, P.E., van Bockxmeer,
            F.M., Hankey, G.J. & Flicker, L. 2012. CRP 1846G A polymorphism increases
            risk of frailty. Maturitas 71(3): 261-266.
  
          
          Annweiler, C., Bataille, R., Ferrière, N.,
            Douillet, D., Fantino, B. & Beauchet, O. 2011. Plasma beta-2 microglobulin
            as a marker of frailty in older adults: A pilot study. The Journals of
              Gerontology Series A: Biological Sciences and Medical Science 66(10):
            1077-1079.
  
          
          Ble, A., Cherubini, A., Volpato, S., Bartali,
            B., Walston, J.D., Windham, B.G. & Ferrucci, L. 2006. Lower plasma vitamin
            E levels are associated with the frailty syndrome: The InCHIANTI study. The
              Journals of Gerontology Series A: Biological Sciences and Medical Sciences 61(3):
            278-283.
  
          
          Brass, E.P., Adler, S., Sietsema, K.E., Hiatt,
            W.R., Orlando, A.M. & Amato, A. 2001. Intravenous L-carnitine increases
            plasma carnitine, reduces fatigue, and may preserve exercise capacity in
            hemodialysis patients. American Journal of Kidney Diseases 37(5):
            1018-1028.
  
          
          Byard, R.W. 2015. Frailty syndrome-medicolegal
            considerations. Journal of Forensic and Legal Medicine 30: 34-38.
  
          
          Calabrese, V., Stella, A.M.G., Calvani, M. &
            Butterfield, D.A. 2006. Acetylcarnitine and cellular stress response: Roles in
            nutritional redox homeostasis and regulation of longevity genes. Journal of
              Nutritional Biochemistry 17(2): 73-88.
  
          
          Campos, Y., Arenas, J., Cabello, A. &
            Gomez-Reino, J.J. 1995. Respiratory chain enzyme defects in patients with
            idiopathic inflammatory myopathy. Annals of the Rheumatic Diseases 54(6):
            491-493.
  
          
          Cavallini, G., Caracciolo, S., Vitali, G.,
            Modenini, F. & Biagiotti, G. 2004. Carnitine versus androgen administration
            in the treatment of sexual dysfunction, depressed mood, and fatigue associated
            with male aging. Urology 63(4): 641-646.
  
          
          Chang, C.I., Chan, D.C.D., Kuo, K.N., Hsiung,
            C.A. & Chen, C.Y. 2010. Vitamin D insufficiency and frailty syndrome in
            older adults living in a Northern Taiwan community. Archives of Gerontology
              and Geriatrics 50: 17-21.
  
          
          Cheng, X., Shen, Y. & Li, R. 2014. Targeting
            TNF: A therapeutic strategy for Alzheimer’s disease. Drug Discovery Today 19(11):
            1822-1827.
  
          
          Chung, H.Y., Cesari, M., Anton, S., Marzetti,
            E., Giovannini, S., Seo, A.Y. & Leeuwenburgh, C. 2009. Molecular
            inflammation: Underpinnings of aging and age-related diseases. Ageing
              Research Reviews 8(1): 18-30.
  
          
          Collerton, J., Martin-Ruiz, C., Davies, K.,
            Hilkens, C.M., Isaacs, J., Kolenda, C. & Jagger, C. 2012. Frailty and the
            role of inflammation, immunosenescence and cellular ageing in the very old:
            Cross-sectional findings from the Newcastle 85+ Study. Mechanisms of Ageing
              and Development 133(6): 456-466.
  
          
          Crentsil, V. 2010. Mechanistic contribution of
            carnitine deficiency to geriatric frailty. Ageing Research Reviews 9(3):
            265-268.
  
          
          Dawson-Hughes, B., Heaney, R.P., Holick, M.F.,
            Lips, P., Meunier, P.J. & Vieth, R. 2005. Estimates of optimal vitamin D
            status. Osteoporosis International 16(7): 713-716.
  
          
          de Gonzalo-Calvo, D., Neitzert, K., Fernández,
            M., Vega-Naredo, I., Caballero, B., García-Macía, M. & Coto-Montes, A.
            2010. Differential inflammatory responses in aging and disease: TNF-α and
            IL-6 as possible biomarkers. Free Radical Biology and Medicine 49(5):
            733-737.
  
          
          Fernández-Garrido, J., Ruiz-Ros, V., Buigues,
            C., Navarro- Martinez, R. & Cauli, O. 2014. Clinical features of prefrail
            older individuals and emerging peripheral biomarkers: A systematic review. Archives
              of Gerontology and Geriatrics 59(1): 7-17.
  
          
          Ferrari, E. & Magri, F. 2008. Role of neuroendocrine
            pathways in cognitive decline during aging. Ageing Research Reviews 7(3):
            225-233.
  
          
          Field, A. 2013. Discovering Statistics using
            IBM SPSS Statistics. 4th ed. London: SAGE Publications Ltd.
  
          
          Fried, L.P., Tangen, C.M., Walston, J., Newman,
            A.B., Hirsch, C., Gottdiener, J. & Burke, G. 2001. Frailty in older adults
            evidence for a phenotype. The Journals of Gerontology Series A: Biological
              Sciences and Medical Sciences 56(3): M146-M157.
  
          
          García-Esquinas, E., Navas-Acien, A.,
            Pérez-Gómez, B. & Artalejo, F.R. 2015. Association of lead and cadmium
            exposure with frailty in US older adults. Environmental Research 137:
            424-431.
  
          
          Hall, J.A. & Jewell, D.E. 2012. Feeding
            healthy beagles medium-chain triglycerides, fish oil, and carnitine offsets
            age-related changes in serum fatty acids and carnitine metabolites. PloS ONE 7(11): e49510.
  
          
          Hubbard, R.E. & Woodhouse, K.W. 2010.
            Frailty, inflammation and the elderly. Biogerontology 11(5): 635-641.
  
          
          Jones, C. & Boelaert, K. 2014. The
            endocrinology of ageing: A mini-review. Gerontology 61(4): 291-300.
  
          
          Kumar, R., Mohan, N., Upadhyay, A.D., Singh,
            A.P., Sahu, V., Dwivedi, S. & Dey, S. 2014. Identification of serum
            sirtuins as novel noninvasive protein markers for frailty. Aging Cell 13(6):
            975-980.
  
          
          Lai, H.Y., Chang, H.T., Lee, Y.L. & Hwang,
            S.J. 2014. Association between inflammatory markers and frailty in
            institutionalized older men. Maturitas 79(3): 329-333.
  
          
          Lang, P., Mitchell, W., Lapenna, A., Pitts, D.
  & Aspinall, R. 2010. Immunological pathogenesis of main age-related
            diseases and frailty: Role of immunosenescence. European Geriatric Medicine 1(2):
            112-121.
  
          
          Leng, S.X., Hung, W., Cappola, A.R., Yu, Q.,
            Xue, Q.L. & Fried, L.P. 2009. White blood cell counts, insulin like growth
            factor-1 levels, and frailty in community-dwelling older women. The Journals
              of Gerontology Series A: Biological Sciences and Medical Sciences 64(4):
            499-502.
  
          
          Malaguarnera, M., Cammalleri, L., Gargante,
            M.P., Vacante, M., Colonna, V. & Motta, M. 2007. L-Carnitine treatment
            reduces severity of physical and mental fatigue and increases cognitive
            functions in centenarians: A randomized and controlled clinical trial. The
              American Journal of Clinical Nutrition 86(6): 1738-1744.
  
          
          Marzetti, E., Calvani, R., Cesari, M., Buford, T.W., Lorenzi, M.,
            Behnke, B.J. & Leeuwenburgh, C. 2013. Mitochondrial dysfunction and
            sarcopenia of aging: From signaling pathways to clinical trials. The
              International Journal of Biochemistry & Cell Biology 45(10): 2288-2301.
  
          
          Mithal, A., Wahl, D.,
            Bonjour, J.P., Burckhardt, P., Dawson- Hughes, B., Eisman, J. &
            Morales-Torres, J. 2009. Global vitamin D status and determinants of
            hypovitaminosis D. Osteoporosis International 20(11): 1807-1820.
  
          
          Mocchegiani, E., Corsonello, A. & Lattanzio, F. 2010.
            Frailty, ageing and inflammation: Reality and perspectives. Biogerontology 11(5):
            523-525.
  
          
          Mohamad, M.I. & Khater, M.S. 2015. Evaluation of insulin
            like growth factor-1 (IGF-1) level and its impact on muscle and bone mineral
            density in frail elderly male. Archives of Gerontology and Geriatrics 60(1):
            124-127.
  
          
          Pertosa, G., Grandaliano, G., Simone, S., Soccio, M. &
            Schena, F.P. 2005. Inflammation and carnitine in hemodialysis patients. Journal
              of Renal Nutrition 15(1): 8-12.
  
          
          Prieto, J.A., Andrade, F., Aldámiz-Echevarría, L. &
            Sanjurjo, P. 2006. Determination of free and total carnitine in plasma by an
            enzymatic reaction and spectrophotometric quantitation spectrophotometric
            determination of carnitine. Clinical Biochemistry 39(10): 1022-1027.
  
          
          Puts, M.T., Visser, M., Twisk, J.W., Deeg, D.J. & Lips,
            P. 2005. Endocrine and inflammatory markers as predictors of frailty. Clinical
              Endocrinology 63(4): 403-411.
  
          
          Rivero, J.L., Sporleder, H.P., Quiroz-Rothe, E., Vervuert,
            I., Coenen, M. & Harmeyer, J. 2002. Oral L-carnitine combined with training
            promotes changes in skeletal muscle. Equine Veterinary Journal 34:
            269-274.
  
          
          Rockwood, K., Andrew, M. & Mitnitski, A. 2007. A
            comparison of two approaches to measuring frailty in elderly people. The
              Journals of Gerontology Series A: Biological Sciences and Medical Sciences 62(7):
            738-743.
  
          
          Saum, K.U., Dieffenbach, A.K., Müezzinler, A., Müller, H.,
            Holleczek, B., Stegmaier, C. & Stammer, H. 2014. Frailty and telomere
            length: Cross-sectional analysis in 3537 older adults from the ESTHER cohort. Experimental
              Gerontology 58: 250-255.
  
          
          Schalk, B.W., Visser, M., Deeg, D.J. & Bouter, L.M.
            2004. Lower levels of serum albumin and total cholesterol and future decline in
            functional performance in older persons: The Longitudinal Aging Study
            Amsterdam. Age and Ageing 33(3): 266-272.
  
          
          Shahar, S., Omar, A., Vanoh, D., Hamid, T.A., Mukari,
            S.Z.M.S., Din, N.C. & Loo, W.H. 2015. Approaches in methodology for
            population-based longitudinal study on neuroprotective model for healthy longevity
            (TUA) among Malaysian older adults. Aging Clinical and Experimental Research 28(6): 1089-1104.
  
          
          Shamsi, K.S., Pierce, A., Ashton, A.S., Halade, D.G.,
            Richardson, A. & Espinoza, S.E. 2012. Proteomic screening of glycoproteins
            in human plasma for frailty biomarkers. The Journals of Gerontology Series
              A: Biological Sciences and Medical Sciences 67(8): 853-864.
  
          
          Villareal, D.T., Banks, M., Siener, C., Sinacore, D.R. &
            Klein, S. 2004. Physical frailty and body composition in obese elderly men and
            women. Obesity Research 12(6): 913-920.
  
          
              Vogt, S., Decke, S., de las Heras Gala, T., Linkohr, B., Koenig, 
                W., Ladwig, K.H., Peters, A. & Thorand, B. 2015. Prospective 
                association of vitamin D with frailty status and all-cause mortality 
                in older adults-Results from the KORA-Age Study. Preventive 
                Medicine 73: 40-46.  
          Walston, J., Arking, D., Fallin, D., Li, T., Beamer, B.,
            Xue, Q. & Chakravarti, A. 2005. IL-6 gene variation is not associated with
            increased serum levels of IL-6, muscle, weakness, or frailty in older women. Experimental
              Gerontology 40(4): 344-352.
  
          
          Weiss, C.O. 2011. Frailty and chronic diseases in older
            adults. Clinics in Geriatric Medicine 27(1): 39-52.
  
          
          Wicherts, I.S., van Schoor, N.M., Boeke, A.J.P., Visser, M.,
            Deeg, D.J., Smit, J. & Lips, P. 2007. Vitamin D status predicts physical
            performance and its decline in older persons. The Journal of Clinical
              Endocrinology & Metabolism 92(6): 2058-2065.
  
          
          
             
          
          *Pengarang
            untuk surat-menyurat; email: suzana.shahar@ukm.edu.my